Supplements And Featured Publications

home / publications / supplements

2023 SOHO Meeting Reporter

Volume: 1

Issue: 1

View Issue

Clinical Updates in Colorectal Cancer

Volume: 1

Issue: 1

View Issue

Novel Approaches Under Evaluation in Gastrointestinal Stromal Tumors

Volume: 1

Issue: 1

View Issue

Research Efforts Are Underway for Follicular Lymphoma

Volume: 1

Issue: 1

View Issue

Novel Approaches Under Evaluation in Melanoma

Volume: 1

Issue: 1

View Issue

ASCO 2023 Meeting Reporter: Updates in GU Cancers

Volume: 1

Issue: 1

View Issue

Updates on Advances Made Across the Breast Cancer Treatment Paradigm

Volume: 1

Issue: 1

View Issue

ASCO and EHA Meeting Reporter: Making the Most of New Data in Myeloproliferative Neoplasms

Volume: 1

Issue: 1

View Issue

Mapping Advances Made With ADCs in Lung Cancer

Volume: 1

Issue: 1

View Issue

Clinical Updates in Primary CNS Lymphoma

Volume: 1

Issue: 1

View Issue

Research Efforts Are Underway for AL Amyloidosis

Volume: 1

Issue: 1

View Issue

Novel Therapeutic Approaches to Target PI3K Mutations in HR+/HER2– Breast Cancer

Volume: 1

Issue: 1

View Issue

My Treatment Approach: Utilizing Test Results to Inform Clinical Decisions in NSCLC

Volume: 1

Issue: 1

View Issue

Research Underway for MYC-Amplified Relapsed or Refractory Solid Tumors

Volume: 1

Issue: 1

View Issue

2023 Genitourinary Cancers Symposium Meeting Reporter

Volume: 1

Issue: 1

View Issue

Research Efforts Underway to Target CEACAM5 in NSCLC

Volume: 1

Issue: 1

View Issue

Focus on Pathways: SERMS in Metastatic Breast Cancer

View Issue

Utilizing Antibody-Drug Conjugates and Other Novel Agents in Lung Cancer

Utilizing Antibody-Drug Conjugates and Other Novel Agents in Lung Cancer comprises articles and videos on experts discussing therapeutic strategies in the pipeline and on the market for their patients with non–small cell lung cancer.

Volume: 1

Issue: 1

View Issue

Milestones in Medicine: Updates in BPDCN

Volume: 1

Issue: 1

View Issue

Novel Approaches to Targeting TSC1/TSC2 Across Malignancies

Volume: 1

Issue: 1

View Issue

Advancing Applications for Antibody-Drug Conjugates in Breast Cancer

Volume: 1

Issue: 1

View Issue

Examining Recent Developments in Frontline HCC Treatment

Volume: 1

Issue: 1

View Issue

Rapid Reviews in Oncology®: September 2022

Volume: 1

Issue: 1

View Issue

Download Issue

Novel Therapeutic Approaches to Target FGFR2 Mutations in Cholangiocarcinoma

Volume: 1

Issue: 1

View Issue

2022 ESMO Meeting Reporter

Volume: 1

Issue: 1

View Issue

Milestones in Medicine: Updates in AML

Volume: 1

Issue: 1

View Issue

Milestones in Medicine: Treatment Developments in Biliary Tract Cancers

Volume: 1

Issue: 1

View Issue

Dermatologists in Cancer Care®: September 2022

Volume: 1

Issue: 1

View Issue

Download Issue

On the Horizon in NSCLC: Antibody Drug Conjugates

View Issue

Novel Therapeutic Approaches to Target FGFR Mutations in Solid Tumors

Volume: 1

Issue: 1

View Issue

1 2 3 4 >

Latest Conference Coverage

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

Second-Line Regorafenib Demonstrates Safety in Advanced HCC, Irrespective of Prior Treatment

First-line Toripalimab Plus Sorafenib Elicits Responses in Unresectable Hepatocellular Carcinoma

Data for Luspatercept Highlight Evolving Treatment Landscape in Lower-Risk MDS

View More Latest Conference Coverage

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512